DTIL - Precision BioSciences, Inc.

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-111,637
-111,637
-30,602
-109,006
-92,877
Depreciation & amortisation
9,004
9,004
10,197
9,813
5,317
Stock-based compensation
19,197
19,197
16,514
13,786
8,940
Change in working capital
24,110
24,110
19,584
-2,014
-2,357
Accounts receivable
-232
-232
9,512
-9,035
-441
Accounts payable
153
153
867
-1,455
667
Other working capital
-49,072
-49,072
-16,656
-92,417
-95,681
Other non-cash items
450
450
-20,403
-
9,940
Net cash provided by operating activities
-45,753
-45,753
-10,853
-87,386
-71,015
Cash flows from investing activities
Investments in property, plant and equipment
-3,319
-3,319
-5,803
-5,031
-24,666
Net cash used for investing activities
-3,319
-3,319
-5,803
-5,031
-24,666
Cash flows from financing activities
Debt repayment
0
0
-2,500
-
-
Common stock issued
74,345
74,345
60,477
0
135,185
Other financing activities
-4,162
-
-13
-
-2,622
Net cash used provided by (used for) financing activities
94,985
94,985
70,521
1,329
173,374
Net change in cash
45,913
45,913
53,865
-91,088
77,693
Cash at beginning of period
143,663
143,663
89,798
180,886
103,193
Cash at end of period
189,576
189,576
143,663
89,798
180,886
Free cash flow
Operating cash flow
-45,753
-45,753
-10,853
-87,386
-71,015
Capital expenditure
-3,319
-3,319
-5,803
-5,031
-24,666
Free cash flow
-49,072
-49,072
-16,656
-92,417
-95,681